PulsePoint

Name: PulsePoint
Brand: PulsePoint

PulsePoint is a technology company using data to accelerate healthcare marketing.

Est 2011|Raised $43.5M|9 Ref Customers

LinkedIn 64K|Web traffic 27K|FTEs 314|HQ New York, New York, US

MarketsDemand-Side Platforms (DSP)

Published Aug 20, 2026

01Common complaints

1. You require independently published security attestations (SOC 2/ISO) before vendor evaluation. Public materials do not list these certifications for PulsePoint. 2. You need a simple, low-minimum-spend self-serve buying experience. PulsePoint appears to operate a sales-led engagement model. 3. Your marketing efforts are not healthcare-specific. Horizontal DSPs (The Trade Desk, DV360, Amazon DSP) may be more appropriate when healthcare identity workflows are not required. 4. You need fully independently validated incremental ROI studies. Vendor case studies and survey results cited in public materials are vendor-published; buyers seeking rigorous incrementality proof should request methodology and raw data. 5. You require a broad set of third-party, community-validated reviews. Public third-party reviews are limited and name collisions complicate validation.

Deal disqualifiers (poor fit)

Very small budgets or teams without programmatic expertise
Requirement for publicly documented SOC 2/ISO certifications before evaluation (unless provided under NDA)
Preference for fully transparent, self-serve posted pricing

Vendor-acknowledged limitations

Privacy policies include standard disclaimers that no security method is completely infallible.
No public SLAs or product limitations were found in reviewed sources.

Roadmap / upcoming features

Vendor communications reference expanded certification opportunities and ongoing product enhancements (e.g., HCP Explorer and optimization feature announcements in 2025).

Scale limitations

No specific scale limitations were documented in public materials.

Security/compliance gaps

Security certifications (SOC 2/ISO) are not publicly documented; buyers should request audit documentation if required.

API limitations / integrations

Public documentation for APIs, SSO, SCIM, audit logs, and similar enterprise integration features was not located in the sources reviewed. Buyers should request integration documentation during technical diligence.

02Why they buy

Unique selling points supported by available evidence (stated as vendor claims)

NPI-level healthcare professional workflows and tooling (product names and feature descriptions reference NPI-level research and activation).
Vendor statements of authenticated/opt-in HCP datasets with a reported relationship to Medscape in vendor communications.
Vendor positioning around programmatic EHR inventory access (including a partnership described with Flora Health).

Where competitors have clearer advantages

Ecosystem breadth and tooling maturity: The Trade Desk and DV360 are generally stronger for cross-vertical omnichannel buying and agency-standard workflows.
Public documentation and transparency: Several competitors provide more publicly accessible technical and security documentation; pricing is still often custom across the category.

Why customers chose PulsePoint (as suggested by vendor/press and limited reviews)

Desire for NPI-level HCP targeting and measurement.
Interest in programmatic EHR/endemic healthcare inventory.
Interest in reducing irrelevant impressions in DTC campaigns through the vendor's optimization messaging.

03Field reports

Review-platform feedback (G2 / Capterra)

Important caveat: Review content for “PulsePoint” is inconsistent across platforms and may reflect different products or entities using the same name. G2 (PulsePoint product page): limited number of reviews with mixed feedback. - Example negative comment (sales/procurement experience): a reviewer reported that a proposal was provided and then retracted without explanation. - Example constructive comment (usage experience): a reviewer described early technical limitations but indicated improvement over time. Capterra listing (appears to refer to a content distribution/marketing product and may not reflect the current healthcare DSP positioning): - Example positive comment: reviewer described the team as responsive and helpful. - Example constructive comment: reviewer suggested more prescriptive campaign recommendations for straightforward goals. What to take from these reviews: - The sample size is small and name collisions are likely. - Recurring themes include dashboard/interface usability, responsiveness of account teams, and at least one significant complaint about the sales/proposal process.

Community / social discussion (public forums / professional social)

Because the PulsePoint name is shared with a public-safety app, some community discussion refers to that app rather than the ad tech platform.

Public forum threads about the public-safety app include reports of changes to alert behavior; these are likely unrelated to the ad tech platform.
Professional social posts from the vendor page described a partnership for EHR programmatic inventory access as presented by the vendor.

Why some customers may leave / avoid

Concerns about sales process reliability based on a negative review.
Potential expectation gaps between automation/AI claims and independently validated methodology.
For smaller advertisers, budget and operational complexity typical of programmatic healthcare buying may be barriers.

Vendor-published case study examples

PulsePoint hosts client case studies behind forms and landing pages. Public snippets include vendor-reported performance improvements; these require diligence to validate. 1) EHR inventory performance claim - Vendor claim: combining health system and ambulatory EHR inventory produced improved HCP reach and reductions in cost-related metrics as described on the vendor landing page. - Critical notes: the landing page is vendor-published and gated, limiting independent verification. Methodology, baseline spend, and measurement definitions are not visible in public snippets. 2) Other success story headlines (examples listed on the hub page) - Vendor-reported headlines reference uplifts in engagement and other outcome metrics. Critical evaluation across case studies: - Metrics are typically presented as "up to" values or percentage uplifts without publicly visible baselines. - Attribution methodology and experimental design are not disclosed in publicly available excerpts. - Buyers should request experiment design details, control group definitions, incrementality testing, and clear definitions of metrics such as cost-related HCP metrics.

Vendor survey-based ROI claim

Vendor communications cite survey-based results claiming customer outcomes. These are survey-based vendor communications; methodology, sample size, and selection criteria are not provided in public excerpts and should be requested for diligence.

04Best fit

Company size

Best fit tends to be mid-market to enterprise healthcare advertisers and agencies with programmatic budgets.
Likely strong fit: pharmaceutical brands, larger healthcare agencies, and health brands investing in ongoing HCP and DTC campaigns.

Industries / verticals

Pharmaceutical manufacturers (Rx and potentially OTC)
Healthcare services brands
Health technology vendors with regulated marketing requirements

Roles and personas

Decision makers: VP/Director of Media, Digital Marketing leadership, Omnichannel Marketing, Media agency leadership, Procurement
Users: Programmatic traders, audience strategists, analytics/insights, marketing operations

Pain points addressed

Targeting HCPs with higher confidence in identity quality (as positioned in vendor materials)
Reducing irrelevant impressions in DTC campaigns through vendor-described optimization features
Consolidating measurement and activation across endemic channels and broader channels

Qualification criteria (good fit)

Needs NPI-level targeting or verified HCP reach
Willing to engage in custom contracting and platform onboarding
Has legal/compliance readiness for healthcare marketing data use

05The pitch

What the product does (objective value proposition)

PulsePoint is a healthcare-focused marketing technology company and a programmatic advertising platform. The platform is used by healthcare brands and agencies to plan, run, and measure omnichannel campaigns using healthcare-specific identity and audience data, including NPI-level HCP targeting, together with analytics and optimization workflows. The product supports both HCP and consumer/patient audiences across channels such as display, mobile, CTV, social, search, and endemic healthcare inventory. Key product concepts described in vendor materials: - NPI-level targeting and measurement for healthcare professional (HCP) marketing. - Authenticated first-party HCP datasets and healthcare publisher data relationships. - AI-driven optimization features intended to improve media efficiency. - Programmatic access to EHR inventory via partner integrations. Notes on claims: Several capabilities above are presented in vendor materials; buyers should validate dataset provenance, optimization methodology, and inventory access during vendor diligence.

Target market and positioning

- Primary buyers: Pharmaceutical manufacturers, healthcare brands, health systems, and healthcare-focused agencies. - Primary users: Media planners, programmatic traders, audience strategists, analytics/insights teams, brand teams, and occasionally sales operations when outputs are integrated into CRM. - Positioning: The product is positioned as an omnichannel activation and measurement platform with healthcare-native identity (NPI) and access to endemic inventory.

Get a comprehensive analysis of PulsePoint including market position, competitive landscape, adoption trends, and peer benchmarks.

Download full report →

Published Aug 20, 2026

01Common complaints

You require independently published security attestations (SOC 2/ISO) before vendor evaluation. Public materials do not list these certifications for PulsePoint.
You need a simple, low-minimum-spend self-serve buying experience. PulsePoint appears to operate a sales-led engagement model.
Your marketing efforts are not healthcare-specific. Horizontal DSPs (The Trade Desk, DV360, Amazon DSP) may be more appropriate when healthcare identity workflows are not required.
You need fully independently validated incremental ROI studies. Vendor case studies and survey results cited in public materials are vendor-published; buyers seeking rigorous incrementality proof should request methodology and raw data.
You require a broad set of third-party, community-validated reviews. Public third-party reviews are limited and name collisions complicate validation.

Deal disqualifiers (poor fit)

Very small budgets or teams without programmatic expertise
Requirement for publicly documented SOC 2/ISO certifications before evaluation (unless provided under NDA)
Preference for fully transparent, self-serve posted pricing

Vendor-acknowledged limitations

Privacy policies include standard disclaimers that no security method is completely infallible.
No public SLAs or product limitations were found in reviewed sources.

Roadmap / upcoming features

Vendor communications reference expanded certification opportunities and ongoing product enhancements (e.g., HCP Explorer and optimization feature announcements in 2025).

Scale limitations

No specific scale limitations were documented in public materials.

Security/compliance gaps

Security certifications (SOC 2/ISO) are not publicly documented; buyers should request audit documentation if required.

API limitations / integrations

Public documentation for APIs, SSO, SCIM, audit logs, and similar enterprise integration features was not located in the sources reviewed. Buyers should request integration documentation during technical diligence.

02Why they buy

Unique selling points supported by available evidence (stated as vendor claims)

NPI-level healthcare professional workflows and tooling (product names and feature descriptions reference NPI-level research and activation).
Vendor statements of authenticated/opt-in HCP datasets with a reported relationship to Medscape in vendor communications.
Vendor positioning around programmatic EHR inventory access (including a partnership described with Flora Health).

Where competitors have clearer advantages

Ecosystem breadth and tooling maturity: The Trade Desk and DV360 are generally stronger for cross-vertical omnichannel buying and agency-standard workflows.
Public documentation and transparency: Several competitors provide more publicly accessible technical and security documentation; pricing is still often custom across the category.

Why customers chose PulsePoint (as suggested by vendor/press and limited reviews)

Desire for NPI-level HCP targeting and measurement.
Interest in programmatic EHR/endemic healthcare inventory.
Interest in reducing irrelevant impressions in DTC campaigns through the vendor's optimization messaging.

03Field reports

Review-platform feedback (G2 / Capterra)

Important caveat: Review content for “PulsePoint” is inconsistent across platforms and may reflect different products or entities using the same name.

G2 (PulsePoint product page): limited number of reviews with mixed feedback.

Example negative comment (sales/procurement experience): a reviewer reported that a proposal was provided and then retracted without explanation.
Example constructive comment (usage experience): a reviewer described early technical limitations but indicated improvement over time.

Capterra listing (appears to refer to a content distribution/marketing product and may not reflect the current healthcare DSP positioning):

Example positive comment: reviewer described the team as responsive and helpful.
Example constructive comment: reviewer suggested more prescriptive campaign recommendations for straightforward goals.

What to take from these reviews:

The sample size is small and name collisions are likely.
Recurring themes include dashboard/interface usability, responsiveness of account teams, and at least one significant complaint about the sales/proposal process.

Community / social discussion (public forums / professional social)

Because the PulsePoint name is shared with a public-safety app, some community discussion refers to that app rather than the ad tech platform.

Public forum threads about the public-safety app include reports of changes to alert behavior; these are likely unrelated to the ad tech platform.
Professional social posts from the vendor page described a partnership for EHR programmatic inventory access as presented by the vendor.

Why some customers may leave / avoid

Concerns about sales process reliability based on a negative review.
Potential expectation gaps between automation/AI claims and independently validated methodology.
For smaller advertisers, budget and operational complexity typical of programmatic healthcare buying may be barriers.

Vendor-published case study examples

PulsePoint hosts client case studies behind forms and landing pages. Public snippets include vendor-reported performance improvements; these require diligence to validate.

EHR inventory performance claim

Vendor claim: combining health system and ambulatory EHR inventory produced improved HCP reach and reductions in cost-related metrics as described on the vendor landing page.
Critical notes: the landing page is vendor-published and gated, limiting independent verification. Methodology, baseline spend, and measurement definitions are not visible in public snippets.

Other success story headlines (examples listed on the hub page)

Vendor-reported headlines reference uplifts in engagement and other outcome metrics.

Critical evaluation across case studies:

Metrics are typically presented as "up to" values or percentage uplifts without publicly visible baselines.
Attribution methodology and experimental design are not disclosed in publicly available excerpts.
Buyers should request experiment design details, control group definitions, incrementality testing, and clear definitions of metrics such as cost-related HCP metrics.

Vendor survey-based ROI claim

04Best fit

Company size

Best fit tends to be mid-market to enterprise healthcare advertisers and agencies with programmatic budgets.
Likely strong fit: pharmaceutical brands, larger healthcare agencies, and health brands investing in ongoing HCP and DTC campaigns.

Industries / verticals

Pharmaceutical manufacturers (Rx and potentially OTC)
Healthcare services brands
Health technology vendors with regulated marketing requirements

Roles and personas

Decision makers: VP/Director of Media, Digital Marketing leadership, Omnichannel Marketing, Media agency leadership, Procurement
Users: Programmatic traders, audience strategists, analytics/insights, marketing operations

Pain points addressed

Targeting HCPs with higher confidence in identity quality (as positioned in vendor materials)
Reducing irrelevant impressions in DTC campaigns through vendor-described optimization features
Consolidating measurement and activation across endemic channels and broader channels

Qualification criteria (good fit)

Needs NPI-level targeting or verified HCP reach
Willing to engage in custom contracting and platform onboarding
Has legal/compliance readiness for healthcare marketing data use

05The pitch

What the product does (objective value proposition)

Key product concepts described in vendor materials:

NPI-level targeting and measurement for healthcare professional (HCP) marketing.
Authenticated first-party HCP datasets and healthcare publisher data relationships.
AI-driven optimization features intended to improve media efficiency.
Programmatic access to EHR inventory via partner integrations.

Notes on claims: Several capabilities above are presented in vendor materials; buyers should validate dataset provenance, optimization methodology, and inventory access during vendor diligence.

Target market and positioning

Primary buyers: Pharmaceutical manufacturers, healthcare brands, health systems, and healthcare-focused agencies.
Primary users: Media planners, programmatic traders, audience strategists, analytics/insights teams, brand teams, and occasionally sales operations when outputs are integrated into CRM.
Positioning: The product is positioned as an omnichannel activation and measurement platform with healthcare-native identity (NPI) and access to endemic inventory.

Get a comprehensive analysis of PulsePoint including market position, competitive landscape, adoption trends, and peer benchmarks.

Download full report →